Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Rapaport

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2021
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid LeukemiaCatherine C Smith, Aaron D Viny, Evan Massi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
Development of an AAV-delivered microRNA gene therapy for Myotonic Dystrophy Type 1Giulio S Tomassy, Wei Fan, Shuwen Cao, et al.
JCI Insight|April 14, 2017
Efficacy of ALK5 inhibition in myelofibrosisLanzhu Yue, Matthias Bartenstein, Wanke Zhao, et al.
The Journal of Experimental Medicine|December 16, 2015
Integrative genetic analysis of mouse and human AML identifies cooperating disease allelesMegan A Hatlen, Kanika Arora, Vladimir Vacic, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2018
Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysisPatrick Maffucci, Benedetta Bigio, Franck Rapaport, et al.
Haematologica|July 16, 2016
Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemiaCatherine C Coombs, David A Sallman, Sean M Devlin, et al.
Leukemia|February 13, 2021
Genomic and evolutionary portraits of disease relapse in acute myeloid leukemiaFranck Rapaport, Yaseswini Neelamraju, Timour Baslan, et al.
Cancer Cell|December 19, 2017
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative NeoplasmsMaria Kleppe, Richard Koche, Lihua Zou, et al.
Cancer Cell|April 11, 2018
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative NeoplasmsMaria Kleppe, Richard Koche, Lihua Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with MyelofibrosisRoni Tamari, Franck Rapaport, Nan Zhang, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2021
Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid LeukemiaCatherine C Smith, Aaron D Viny, Evan Massi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 4, 2025
Development of an AAV-delivered microRNA gene therapy for Myotonic Dystrophy Type 1Giulio S Tomassy, Wei Fan, Shuwen Cao, et al.
JCI Insight|April 14, 2017
Efficacy of ALK5 inhibition in myelofibrosisLanzhu Yue, Matthias Bartenstein, Wanke Zhao, et al.
The Journal of Experimental Medicine|December 16, 2015
Integrative genetic analysis of mouse and human AML identifies cooperating disease allelesMegan A Hatlen, Kanika Arora, Vladimir Vacic, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2018
Blacklisting variants common in private cohorts but not in public databases optimizes human exome analysisPatrick Maffucci, Benedetta Bigio, Franck Rapaport, et al.
Haematologica|July 16, 2016
Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemiaCatherine C Coombs, David A Sallman, Sean M Devlin, et al.
Leukemia|February 13, 2021
Genomic and evolutionary portraits of disease relapse in acute myeloid leukemiaFranck Rapaport, Yaseswini Neelamraju, Timour Baslan, et al.
Cancer Cell|December 19, 2017
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative NeoplasmsMaria Kleppe, Richard Koche, Lihua Zou, et al.
Cancer Cell|April 11, 2018
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative NeoplasmsMaria Kleppe, Richard Koche, Lihua Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with MyelofibrosisRoni Tamari, Franck Rapaport, Nan Zhang, et al.
Pageof 6